NCT01813474View on ClinicalTrials.gov

Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 25, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
CancerAdvanced Solid Malignancies
Interventions
DRUG

olaparib

tablet oral

Trial Locations (3)

104-0045

Research Site, Chūōku

811-1395

Research Site, Fukuoka

003-0804

Research Site, Sapporo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY